-+ 0.00%
-+ 0.00%
-+ 0.00%

PROPANC BIOPHARMA REPORTS PRECLINICAL DATA WITH PRP & PRP PLUS TGF-Β INHIBITOR ON TGF-Β PATHWAY IN PANCREATIC CANCER

Reuters·11/02/2026 13:30:01

Please log in to view news